In this episode, we explore the intricacies of the Elite Rated Morgan Stanley Global Brands fund. Candida de Silva, portfolio specialist on the fund, provides insights into their strategy of holding high-quality companies with defendable, visible future earnings, emphasising the long-term ownership of these businesses. We discuss the selection of companies, their competitive advantages, and how they adapt to evolving market dynamics while maintaining robust growth.
What’s covered in this episode:
- “We don't rent stocks, we own businesses for the long term”
- How the portfolio evolves over time
- The growing popularity of healthcare in the portfolio
- Is anti-globalisation and re-shoring a threat to global brands?
- How have companies managed inflation?
More about the fund:
The investment team behind Morgan Stanley Global Brands have a mantra: ‘don’t lose money’, which will possibly be as comforting to investors as the familiar names that can be found in the portfolio. The fund is a very concentrated portfolio of high-quality global companies, with features such as strong network benefits and brands, or licenses and permits that can provide an advantage over competitors. They will also look for companies benefiting from economies of scale and leading market distribution.
Disclaimer:
The fund mentioned herein is available to UK investors only. All investments involve risk, including the loss of principle. Full details and risks associated with the fund can be found in the fund’s Prospectus at www.morganstanleyfunds.co.uk. The fund is available through your Investment Adviser and applications for shares in the fund should not be made without first consulting the current Prospectus, Key Investor Information Document ("KIID"), Annual Report and Semi Annual Report (“Offering Documents”), or other documents available in your local jurisdiction. This content has been prepared solely for informational purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy.
Learn more on fundcalibre.com
Please remember, we’ve been discussing individual companies to bring investing to life for you. It’s not a recommendation to buy or sell. The fund may or may not still hold these companies at the time of listening. Elite Ratings are based on FundCalibre’s research methodology and are the opinion of FundCalibre’s research team only.
Information
- Show
- FrequencyUpdated weekly
- Published5 June 2024 at 23:00 UTC
- Length13 min
- RatingClean